Revenue | ₹1,959.39Cr |
Net Profits | ₹153.72Cr |
Net Profit Margins | 7.85% |
Emcure Pharmaceuticals Ltd’s revenue jumped 15.49% since last year same period to ₹1,959.39Cr in the Q3 2024-2025. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated -3.84% fall in its revenue since last 3-months.
Emcure Pharmaceuticals Ltd’s net profit jumped 35.5% since last year same period to ₹153.72Cr in the Q3 2024-2025. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated -21% fall in its net profits since last 3-months.
Emcure Pharmaceuticals Ltd’s net profit margin jumped 17.32% since last year same period to 7.85% in the Q3 2024-2025. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated -17.84% fall in its net profit margins since last 3-months.
The revenue for Emcure Pharmaceuticals Ltd in the Q3 results 2024 was ₹1,959.39Cr.
The net profit for Emcure Pharmaceuticals Ltd in the Q3 results 2024 was ₹153.72Cr.
The net profit margin for Emcure Pharmaceuticals Ltd in the Q3 results 2024 was 7.85%.
The revenue for Emcure Pharmaceuticals Ltd in the Q3 results 2023 was ₹1,696.58Cr.
The net profit for Emcure Pharmaceuticals Ltd in the Q3 results 2023 was ₹113.45Cr.
The net profit margin for Emcure Pharmaceuticals Ltd in the Q3 results 2023 was 6.69%.